EUSA Pharma Competitors and Similar CompaniesClear all
Immunomedics's competitors and similar companies include BioLineRx.
 Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. | ||
Founding Date | Founding Date 1982 | Founding Date 2003 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Morris Plains, US HQ | Locations Modi'in-Maccabim-Re'ut, IL HQ |
Employees | Employees 8914% decrease | Employees 2414% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $295k (FY, 2019) | Revenue (est.) $1.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $230k (FY, 2025) |
Gross profit | Gross profit $295k (FY, 2019) | Gross profit $950k (FY, 2025) |
Net income | Net income ($357.3m) (FY, 2019) | Net income ($2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 30m | Total funding raised $ 100.9m |
For sources of this data, please see the company profile
View Company Profiles
BioLineRx
HQ
Modi'in-Maccabim-Re'ut, IL
Employees
24↓ 14% decrease
BioLineRx is a biopharmaceutical company focused on oncology.
View company